Current treatment of heart failure with preserved ejection fraction: should we add life to the remaining years or add years to the remaining life?
about
Challenging aspects of treatment strategies in heart failure with preserved ejection fraction: "Why did recent clinical trials fail?"Hemodynamic monitoring in heart failure and pulmonary hypertension: From analog tracings to the digital ageExploring Guidelines for Classification of Major Heart Failure Subtypes by Using Machine Learning.Physical therapy in heart failure with preserved ejection fraction: A systematic review.Bariatric Surgery-Induced Cardiac and Lipidomic Changes in Obesity-Related Heart Failure with Preserved Ejection Fraction.Sex differences in ischemic heart disease and heart failure biomarkers
P2860
Current treatment of heart failure with preserved ejection fraction: should we add life to the remaining years or add years to the remaining life?
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 24 October 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Current treatment of heart fai ...... d years to the remaining life?
@en
Current treatment of heart fai ...... d years to the remaining life?
@nl
type
label
Current treatment of heart fai ...... d years to the remaining life?
@en
Current treatment of heart fai ...... d years to the remaining life?
@nl
prefLabel
Current treatment of heart fai ...... d years to the remaining life?
@en
Current treatment of heart fai ...... d years to the remaining life?
@nl
P2093
P2860
P356
P1476
Current treatment of heart fai ...... d years to the remaining life?
@en
P2093
Dirk Westermann
Peter Moritz Becher
Stefan Blankenberg
P2860
P304
P356
10.1155/2013/130724
P577
2013-10-24T00:00:00Z